Jump to the main content block
:::

Artificial Intelligence

Print
Data Source:研創暨智慧醫療中心       

AI-Aided Analysis and Prediction Models for Infectious Diseases: We have achieved significant breakthroughs in the application of artificial intelligence in medicine, particularly demonstrating excellence in the diagnosis of infectious diseases and the construction of predictive models. In the identification of medical fungi, our research team successfully employed deep learning technology to establish a high-precision image recognition model capable of accurately identifying various fungal genera, including Aspergillus, Cladosporium, and Penicillium. Utilizing advanced Convolutional Neural Networks (CNN) and YOLO v7 technology, this system achieved an impressive overall accuracy of 90.1% in image classification, enabling rapid screening of different fungal types and effectively assisting clinical medical diagnosis. The study collected over 7,226 images, including 2,464 from Google and 4,762 from 229 clinical specimens, showcasing the team's expertise in handling large datasets.

In the field of detecting multidrug-resistant (MDR) bacteria, the hospital's research team developed an innovative machine learning predictive model. By successfully employing MALDI-TOF mass spectrometry technology and complex machine learning algorithms, the model accurately detects high-risk Vancomycin-Resistant Enterococci (VRE). The research utilized nine machine learning algorithms, including Support Vector Machines (SVM), Random Forest, and Bayesian classifiers, and employed Stacking Ensemble Learning techniques to establish an intelligent system capable of real-time detection of bacterial resistance. This breakthrough not only enhances the effectiveness of hospital infection control but also pioneers new technological pathways for precision medicine. During the research, the team analyzed 6,391 enterococcal isolates, 52.8% of which were MDR strains, demonstrating deep insight and analytical capabilities regarding medical big data and providing more precise technical support for clinical infection control.

Our hospital's AI research team has demonstrated remarkable innovation in data processing and model construction, particularly in pioneering data segmentation and labeling methods. In the fungal image recognition project, researchers adopted a unique image segmentation strategy ensuring that images from the same specimen did not appear in both training and testing sets, effectively preventing data leakage. In the bacterial resistance prediction model, the team developed dynamically adjusted machine learning methods capable of flexibly adapting the prediction model based on the characteristics of bacterial strains from different years, showcasing high technical flexibility and foresight. These innovative methods not only improve model accuracy but also set new benchmarks for the development of medical artificial intelligence. The team plans to further shorten the collection time for training datasets, focusing the prediction scope on the upcoming six months, demonstrating a spirit of continuous optimization and innovation, thereby opening new possibilities for the future of smart healthcare.

:::